BCAB as of Nov 4 · 03:43 ET
BCABNasdaqBiological Products, (No Diagnostic Substances)
BioAtla, Inc. · Brief
Next report
6 days
Nov 10 · after closeest.Q3 FY26
Expected move
InputsImplied vs realized
HistoryNo reported quarters.
Bull & bear
Nov 10 report · est.—
Linked exposure
BCAB report sessionNo linked exposure.
Oct 208-KMaterial agreement: Standby Equity Purchase Agreement with YA II PN, Ltd., a Cayman Islands exempt limited company ("Yorkville").Source
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.